首頁 > 市場調查報告書 > 製藥

疼痛

市場調查報告書

商品編碼

1547755

全球疼痛管理治療市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Pain Management Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球疼痛管理治療市場需求預計將從 2023 年的 782.8 億美元達到近 1,213.4 億美元的市場規模，2024-2034 年研究期間複合年成長率為 4.99%。

疼痛管理療法包括一系列旨在減輕或控制疼痛的藥物、治療和介入。該領域致力於解決急性和慢性疼痛問題。這些可能包括鎮痛藥物（鴉片類藥物、非類固醇抗發炎藥和抗憂鬱藥），以及物理治療、針灸和神經阻斷等非藥物方法。目標是改善遭受疼痛的個人的生活品質和功能能力，同時最大限度地減少不良影響和依賴性的風險。

市場動態

疼痛管理治療市場成長的主要原因是慢性疼痛和癌症相關疼痛的發生率不斷上升。隨著人口老化和生活方式的改變導致慢性疼痛疾病的發生率更高，因此需要有效的疼痛管理解決方案。此外，藥物研究和開發的進步導致了療效和安全性提高的創新療法的推出，進一步推動了市場擴張。此外，醫療保健專業人員和患者現在更加意識到疼痛管理的重要性，而新型治療方案的可用性正在促進市場成長。此外，疼痛管理療法在骨科、神經病學和腫瘤學等各個醫學專業中的廣泛應用正在促進市場成長。

個人化醫療和精準醫療的趨勢正在進一步推動針對滿足每位患者特定需求的針對性疼痛管理療法的開發，從而刺激市場創新。最後，旨在改善疼痛管理治療機會的有利報銷政策和措施正在促進市場成長，特別是在醫療基礎設施不斷發展的新興經濟體。然而，嚴格的監管批准和潛在的副作用可能會阻礙未來幾年疼痛管理治療市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球疼痛管理治療市場的每個細分市場進行了包容性評估。疼痛管理治療產業的成長和趨勢為本研究提供了整體方法。

市場區隔

疼痛管理治療市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按藥物類別

非類固醇抗發炎藥
麻醉劑
抗驚厥藥
抗偏頭痛藥物
抗憂鬱藥
鴉片類藥物
非麻醉藥品
止痛藥

按指示

關節炎疼痛
神經性疼痛
癌症痛
慢性疼痛
術後疼痛
偏頭痛
纖維肌痛
骨折
肌肉扭傷/拉傷
急性闌尾炎
其他

按疼痛類型

慢性的
急性

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲疼痛管理治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。疼痛管理治療市場的主要參與者包括葛蘭素史克公司、諾華公司、雅培實驗室、禮來公司、Endo Health Solutions Inc.、輝瑞公司、普渡製藥公司、默克公司、Mylan NV.、強生公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：疼痛管理治療公司的競爭格局

疼痛管理治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
GlaxoSmithKline Plc.

公司概況
公司收入
產品
最新動態

Novartis AG

公司概況
公司收入
產品
最新動態

Abbott Laboratories

公司概況
公司收入
產品
最新動態

Eli Lilly & Company

公司概況
公司收入
產品
最新動態

Endo Health Solutions Inc.

公司概況
公司收入
產品
最新動態

Pfizer Inc.

公司概況
公司收入
產品
最新動態

Purdue Pharma LP

公司概況
公司收入
產品
最新動態

Merck & Co. Inc.

公司概況
公司收入
產品
最新動態

Mylan NV.

公司概況
公司收入
產品
最新動態

Johnson & Johnson

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11213511

The global demand for Pain Management Therapeutics Market is presumed to reach the market size of nearly USD 121.34 Billion by 2032 from USD 78.28 Billion in 2023 with a CAGR of 4.99% under the study period 2024-2034.

Pain management therapeutics encompass a range of medications, treatments, and interventions aimed at alleviating or managing pain. This field addresses acute and chronic pain conditions. These may include analgesic medications (opioids, nonsteroidal anti-inflammatory drugs, and antidepressants), as well as non-pharmacological approaches like physical therapy, acupuncture, and nerve blocks. The goal is to improve quality of life and functional ability for individuals experiencing pain while minimizing the risks of adverse effects and dependency.

MARKET DYNAMICS

The primary reason behind the growth of the pain management therapeutics market is the rising incidence of chronic pain conditions and pain associated with cancer. With aging populations and lifestyle changes leading to higher incidences of chronic pain disorders, there is a demand for effective pain management solutions. Additionally, advancements in pharma research and development have led to the introduction of innovative therapeutics with improved efficacy and safety profiles, further driving market expansion. Moreover, the healthcare professionals and patients are now more aware regarding the importance of pain management and the availability of novel treatment options is fostering the market growth. Furthermore, the expanding application of pain management therapeutics across various medical specialties, including orthopedics, neurology, and oncology, is contributing to market growth.

The trend toward personalized medicine and precision healthcare is fueling a greater push for the development of targeted pain management therapies customized to meet the specific needs of each patient, thereby spurring innovation within the market. Lastly, favorable reimbursement policies and initiatives aimed at improving access to pain management treatments are facilitating market growth, particularly in emerging economies where healthcare infrastructure is evolving. However, stringent regulatory approvals and potential side effects may hinder the growth of the pain management therapeutics market in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Pain Management Therapeutics. The growth and trends of Pain Management Therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Pain Management Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

NSAIDS
Anesthetics
Anticonvulsant
Anti-Migraine Drugs
Antidepressant Drugs
Opioids
Non-Narcotics
Analgesics

By Indication

Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Pain
Post-Operative Pain
Migraine
Fibromyalgia
Bone Fracture
Muscle Sprain/Strain
Acute Appendicitis
Other

By Pain Type

Chronic
Acute

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pain Management Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pain Management Therapeutics market include GlaxoSmithKline Plc., Novartis AG, Abbott Laboratories, Eli Lilly & Company, Endo Health Solutions Inc., Pfizer Inc., Purdue Pharma L.P., Merck & Co. Inc., Mylan NV., Johnson & Johnson. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PAIN MANAGEMENT THERAPEUTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Class
- 3.7.2 Market Attractiveness Analysis By Indication
- 3.7.3 Market Attractiveness Analysis By Pain Type
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS

5.1. Overview By Drug Class
5.2. Historical and Forecast Data
5.3. Analysis By Drug Class
5.4. NSAIDS Historic and Forecast Sales By Regions
5.5. Anesthetics Historic and Forecast Sales By Regions
5.6. Anticonvulsant Historic and Forecast Sales By Regions
5.7. Anti-Migraine Drugs Historic and Forecast Sales By Regions
5.8. Antidepressant Drugs Historic and Forecast Sales By Regions
5.9. Opioids Historic and Forecast Sales By Regions
5.10. Non-Narcotics Historic and Forecast Sales By Regions
5.11. Analgesics Historic and Forecast Sales By Regions

6. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET ANALYSIS BY INDICATION

6.1. Overview By Indication
6.2. Historical and Forecast Data
6.3. Analysis By Indication
6.4. Arthritic Pain Historic and Forecast Sales By Regions
6.5. Neuropathic Pain Historic and Forecast Sales By Regions
6.6. Cancer Pain Historic and Forecast Sales By Regions
6.7. Chronic Pain Historic and Forecast Sales By Regions
6.8. Post-Operative Pain Historic and Forecast Sales By Regions
6.9. Migraine Historic and Forecast Sales By Regions
6.10. Fibromyalgia Historic and Forecast Sales By Regions
6.11. Bone Fracture Historic and Forecast Sales By Regions
6.12. Muscle Sprain/Strain Historic and Forecast Sales By Regions
6.13. Acute Appendicitis Historic and Forecast Sales By Regions
6.14. Other Historic and Forecast Sales By Regions

7. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET ANALYSIS BY PAIN TYPE

7.1. Overview By Pain Type
7.2. Historical and Forecast Data
7.3. Analysis By Pain Type
7.4. Chronic Historic and Forecast Sales By Regions
7.5. Acute Historic and Forecast Sales By Regions

8. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PAIN MANAGEMENT THERAPEUTICS COMPANIES

9.1. Pain Management Therapeutics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF PAIN MANAGEMENT THERAPEUTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. GlaxoSmithKline Plc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Novartis AG
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Abbott Laboratories
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Eli Lilly & Company
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Endo Health Solutions Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Pfizer Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Purdue Pharma L.P.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Merck & Co. Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Mylan NV.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Johnson & Johnson
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments